Clinical Trial Update: A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable [Phase 1]

View source ↗

Summary

Phase 1 study of GDC-0941 (pictilisib) in patients with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• GDC-0941 (GDC-0941)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Hodgkin's Lymphoma, Solid Cancers | Phase 1 | Status: COMPLETED